CN115040613B - 改善病毒性感冒发热症状的中药组合物、应用及制剂 - Google Patents
改善病毒性感冒发热症状的中药组合物、应用及制剂 Download PDFInfo
- Publication number
- CN115040613B CN115040613B CN202210928792.3A CN202210928792A CN115040613B CN 115040613 B CN115040613 B CN 115040613B CN 202210928792 A CN202210928792 A CN 202210928792A CN 115040613 B CN115040613 B CN 115040613B
- Authority
- CN
- China
- Prior art keywords
- parts
- traditional chinese
- chinese medicine
- root
- medicine composition
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 107
- 239000000203 mixture Substances 0.000 title claims abstract description 57
- 206010037660 Pyrexia Diseases 0.000 title claims abstract description 34
- 206010022000 influenza Diseases 0.000 title claims abstract description 33
- 208000024891 symptom Diseases 0.000 title claims abstract description 33
- 230000003612 virological effect Effects 0.000 title claims abstract description 31
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 235000003130 Arctium lappa Nutrition 0.000 claims abstract description 28
- 235000008078 Arctium minus Nutrition 0.000 claims abstract description 27
- 235000017166 Bambusa arundinacea Nutrition 0.000 claims abstract description 25
- 235000017491 Bambusa tulda Nutrition 0.000 claims abstract description 25
- 235000015334 Phyllostachys viridis Nutrition 0.000 claims abstract description 25
- 244000274050 Platycodon grandiflorum Species 0.000 claims abstract description 25
- 239000011425 bamboo Substances 0.000 claims abstract description 25
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 claims abstract description 16
- 244000303040 Glycyrrhiza glabra Species 0.000 claims abstract description 13
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims abstract description 13
- 235000011477 liquorice Nutrition 0.000 claims abstract description 13
- 235000006753 Platycodon grandiflorum Nutrition 0.000 claims abstract description 9
- 235000006679 Mentha X verticillata Nutrition 0.000 claims abstract description 7
- 235000002899 Mentha suaveolens Nutrition 0.000 claims abstract description 7
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims abstract description 7
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract 5
- 241001330002 Bambuseae Species 0.000 claims description 24
- 241000951473 Schizonepeta Species 0.000 claims description 19
- 244000246386 Mentha pulegium Species 0.000 claims description 18
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 18
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 18
- 235000001050 hortel pimenta Nutrition 0.000 claims description 18
- 241000576429 Forsythia suspensa Species 0.000 claims description 17
- 241000219784 Sophora Species 0.000 claims description 17
- MFYSUUPKMDJYPF-UHFFFAOYSA-N 2-[(4-methyl-2-nitrophenyl)diazenyl]-3-oxo-n-phenylbutanamide Chemical compound C=1C=CC=CC=1NC(=O)C(C(=O)C)N=NC1=CC=C(C)C=C1[N+]([O-])=O MFYSUUPKMDJYPF-UHFFFAOYSA-N 0.000 claims description 16
- 235000006751 Platycodon Nutrition 0.000 claims description 16
- 235000002226 Ranunculus ficaria Nutrition 0.000 claims description 16
- 241000405414 Rehmannia Species 0.000 claims description 16
- 241001530126 Scrophularia Species 0.000 claims description 16
- 229930189914 platycodon Natural products 0.000 claims description 16
- 239000002552 dosage form Substances 0.000 claims description 2
- 239000008187 granular material Substances 0.000 claims description 2
- 238000004519 manufacturing process Methods 0.000 claims description 2
- 241000208843 Arctium Species 0.000 claims 4
- 240000005528 Arctium lappa Species 0.000 abstract description 24
- 208000021760 high fever Diseases 0.000 abstract description 20
- 230000004044 response Effects 0.000 abstract description 4
- 230000009286 beneficial effect Effects 0.000 abstract description 3
- 244000082204 Phyllostachys viridis Species 0.000 abstract 1
- 230000036760 body temperature Effects 0.000 description 30
- 241001570521 Lonicera periclymenum Species 0.000 description 20
- 230000000694 effects Effects 0.000 description 13
- 229940079593 drug Drugs 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 235000018142 Hedysarum alpinum var americanum Nutrition 0.000 description 9
- 240000006461 Hedysarum alpinum var. americanum Species 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- 239000002994 raw material Substances 0.000 description 8
- 230000006872 improvement Effects 0.000 description 7
- 231100000331 toxic Toxicity 0.000 description 7
- 230000002588 toxic effect Effects 0.000 description 7
- 208000011580 syndromic disease Diseases 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 229960003752 oseltamivir Drugs 0.000 description 5
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 201000007100 Pharyngitis Diseases 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 201000009240 nasopharyngitis Diseases 0.000 description 4
- VSZGPKBBMSAYNT-RRFJBIMHSA-N oseltamivir Chemical compound CCOC(=O)C1=C[C@@H](OC(CC)CC)[C@H](NC(C)=O)[C@@H](N)C1 VSZGPKBBMSAYNT-RRFJBIMHSA-N 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 230000001737 promoting effect Effects 0.000 description 4
- 206010007247 Carbuncle Diseases 0.000 description 3
- 206010011224 Cough Diseases 0.000 description 3
- 241000202807 Glycyrrhiza Species 0.000 description 3
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 3
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 3
- 206010042674 Swelling Diseases 0.000 description 3
- 230000009471 action Effects 0.000 description 3
- 239000008280 blood Substances 0.000 description 3
- 210000004369 blood Anatomy 0.000 description 3
- 238000001816 cooling Methods 0.000 description 3
- 229940010454 licorice Drugs 0.000 description 3
- 230000008961 swelling Effects 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 201000000297 Erysipelas Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 240000003915 Lophatherum gracile Species 0.000 description 2
- 102000005348 Neuraminidase Human genes 0.000 description 2
- 108010006232 Neuraminidase Proteins 0.000 description 2
- 206010068319 Oropharyngeal pain Diseases 0.000 description 2
- 208000003251 Pruritus Diseases 0.000 description 2
- 241000207844 Scrophulariaceae Species 0.000 description 2
- 208000005392 Spasm Diseases 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 230000000840 anti-viral effect Effects 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000009929 lianhuaqingwen Substances 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000007170 pathology Effects 0.000 description 2
- 230000002085 persistent effect Effects 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000035900 sweating Effects 0.000 description 2
- 231100000419 toxicity Toxicity 0.000 description 2
- 230000001988 toxicity Effects 0.000 description 2
- 241000712461 unidentified influenza virus Species 0.000 description 2
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 241000332371 Abutilon x hybridum Species 0.000 description 1
- 206010063409 Acarodermatitis Diseases 0.000 description 1
- 241000722941 Achillea Species 0.000 description 1
- 244000205574 Acorus calamus Species 0.000 description 1
- 235000006480 Acorus calamus Nutrition 0.000 description 1
- XOJVHLIYNSOZOO-SWOBOCGESA-N Arctiin Chemical compound C1=C(OC)C(OC)=CC=C1C[C@@H]1[C@@H](CC=2C=C(OC)C(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)=CC=2)C(=O)OC1 XOJVHLIYNSOZOO-SWOBOCGESA-N 0.000 description 1
- 241000208838 Asteraceae Species 0.000 description 1
- 208000035143 Bacterial infection Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 241001045268 Desmanthus cooleyi Species 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- 241000220485 Fabaceae Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- 240000008917 Glycyrrhiza uralensis Species 0.000 description 1
- 235000000554 Glycyrrhiza uralensis Nutrition 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 241000825107 Hierochloe Species 0.000 description 1
- 235000015466 Hierochloe odorata Nutrition 0.000 description 1
- 208000008454 Hyperhidrosis Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010024642 Listless Diseases 0.000 description 1
- 244000167230 Lonicera japonica Species 0.000 description 1
- 235000017617 Lonicera japonica Nutrition 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 description 1
- 244000280293 Mentha haplocalyx Species 0.000 description 1
- 240000009215 Nepeta cataria Species 0.000 description 1
- 235000010679 Nepeta cataria Nutrition 0.000 description 1
- 241000207834 Oleaceae Species 0.000 description 1
- 208000002193 Pain Diseases 0.000 description 1
- 206010033557 Palpitations Diseases 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 208000008350 Pruritus Vulvae Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000405911 Rehmannia glutinosa Species 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010039424 Salivary hypersecretion Diseases 0.000 description 1
- 241000447727 Scabies Species 0.000 description 1
- 235000013559 Schnittsellerie Nutrition 0.000 description 1
- 244000169997 Schnittsellerie Species 0.000 description 1
- 241001121987 Scrophularia ningpoensis Species 0.000 description 1
- 206010040007 Sense of oppression Diseases 0.000 description 1
- 241000246044 Sophora flavescens Species 0.000 description 1
- 206010070863 Toxicity to various agents Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010047473 Viral pharyngitis Diseases 0.000 description 1
- 206010047700 Vomiting Diseases 0.000 description 1
- 206010056530 Vulvovaginal pruritus Diseases 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 208000022362 bacterial infectious disease Diseases 0.000 description 1
- SQVRNKJHWKZAKO-UHFFFAOYSA-N beta-N-Acetyl-D-neuraminic acid Natural products CC(=O)NC1C(O)CC(O)(C(O)=O)OC1C(O)C(O)CO SQVRNKJHWKZAKO-UHFFFAOYSA-N 0.000 description 1
- 208000034158 bleeding Diseases 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- -1 carboxyl oseltamivir Chemical compound 0.000 description 1
- 238000012512 characterization method Methods 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000035619 diuresis Effects 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000071 effect on fever Effects 0.000 description 1
- 125000004494 ethyl ester group Chemical group 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 230000020169 heat generation Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000007803 itching Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 208000017971 listlessness Diseases 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229940126701 oral medication Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001717 pathogenic effect Effects 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229940002612 prodrug Drugs 0.000 description 1
- 239000000651 prodrug Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 208000026451 salivation Diseases 0.000 description 1
- 208000005687 scabies Diseases 0.000 description 1
- SQVRNKJHWKZAKO-OQPLDHBCSA-N sialic acid Chemical compound CC(=O)N[C@@H]1[C@@H](O)C[C@@](O)(C(O)=O)OC1[C@H](O)[C@H](O)CO SQVRNKJHWKZAKO-OQPLDHBCSA-N 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000167 toxic agent Toxicity 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 229940126680 traditional chinese medicines Drugs 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
- 210000001835 viscera Anatomy 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 229940126673 western medicines Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/804—Rehmannia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/34—Campanulaceae (Bellflower family)
- A61K36/346—Platycodon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/484—Glycyrrhiza (licorice)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
- A61K36/489—Sophora, e.g. necklacepod or mamani
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/63—Oleaceae (Olive family), e.g. jasmine, lilac or ash tree
- A61K36/634—Forsythia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/80—Scrophulariaceae (Figwort family)
- A61K36/808—Scrophularia (figwort)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation or decoction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Medical Informatics (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Microbiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Alternative & Traditional Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pulmonology (AREA)
- Virology (AREA)
- Oncology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Otolaryngology (AREA)
- Molecular Biology (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本申请涉及改善病毒性感冒伴随的发热症状的中药组合物、应用及制剂,具体而言,所述中药组合物,由以下按重量份数计的各成分组成:生地10~20份、玄参15~25份、苦参15~25份、金银花15~25份、连翘15~25份、牛蒡子15~25份、桔梗15~25份、薄荷5~10份、竹叶5~10份、荆芥10~20份和甘草10~20份。本申请中药组合物在同样缓解病毒性感冒各项伴随症状的同时,还可有效且快速改善病毒性感冒伴随的发热症状,起效快,减少反复,更有利于高热症状患者(例如39℃以上高热患者),以及更适用于婴幼儿高热或高热反复症状的患者。
Description
技术领域
本申请涉及一种中药组合物、应用及制剂,具体可涉及一种可有效且快速改善病毒性感冒伴随的发热症状的中药组合物、应用及制剂。
背景技术
目前治疗病毒性感冒的药物中,西药大多以奥司他韦为首选药物,中药大多以连花清瘟、抗病毒口服液等为首选药物。
奥斯他韦,商品名达菲,奥司他韦是一种神经氨酸酶(诞酶)抑制药的乙酯前体药,口服后在人体内经酯酶的作用转变成活性型的羧基奥司他韦,后者与流感病毒表面的神经氨酸酶结合,抑制该酶切断受感染细胞表面的唾液酸的作用,因而阻止了新生的流感病毒颗粒,从受染细胞释出。2019年日本厚生劳动省和日本药械管理局联合宣布,服用奥司他韦的患者出现了出血的症状,此后,奥斯他韦被西医列为慎用药物。
在目前治疗病毒性感冒的中药药物中,大多是以整体缓解其并发症状为主要治疗效果,包括咽痛、咳嗽、四肢酸痛、发热等;在用药过程中,上述症状虽能有所缓解,但依然存在针对于发热症状起效慢、发热反复等问题。尤其是在婴幼儿用药的情形下,若不能及时快速的改善发热问题,高热或反复高热可能带来的对婴幼儿的后遗症的概率就有可能增加。
发明内容
本申请的目的在于提供一种改善病毒性感冒发热症状的中药组合物、应用及制剂,该中药组合物针对于病毒性感冒伴随的发热症状可以快速起效,减少反复,从而减少高热或反复高热所带来的后遗症的可能,尤其是减少对婴幼儿高热或反复高热所带来的后遗症的可能。
本申请所提供的第一种方案为:
改善病毒性感冒发热症状的中药组合物,由以下按重量份数计的各成分组成:
生地10~20份、玄参15~25份、苦参15~25份、金银花15~25份、连翘15~25份、牛蒡子15~25份、桔梗15~25份、薄荷5~10份、竹叶5~10份、荆芥10~20份和甘草10~20份。
进一步地,所述中药组合物由以下按重量份数计的各成分组成:
生地10~15份、玄参15~20份、苦参15~20份、金银花15~20份、连翘15~20份、牛蒡子15~20份、桔梗15~20份、薄荷5~10份、竹叶5~10份、荆芥10~15份、甘草10~15份。
进一步地,所述中药组合物由以下按重量份数计的各成分组成:生地15份、玄参15份、苦参15份、金银花20份、连翘20份、牛蒡子15份、桔梗15份、荆芥10份、薄荷5份、竹叶5份、甘草10份。
进一步地,所述中药组合物由以下按重量份数计的各成分组成:生地15份、玄参15份、苦参15份、金银花20份、连翘20份、牛蒡子20份、桔梗15份、薄荷10份、竹叶5份、荆芥10份、甘草10份。
进一步地,所述中药组合物由以下按重量份数计的各成分组成:生地15份、玄参15份、苦参15份、金银花20份、连翘20份、牛蒡子15份、桔梗15份、薄荷5份、竹叶5份、荆芥I0份、甘草I0份。
进一步地,所述中药组合物由以下按重量份数计的各成分组成:生地10份、玄参15份、苦参15份、金银花20份、连翘20份、牛蒡子15份、桔梗15份、薄荷5份、竹叶5份、 荆芥10份、甘草10份。
本申请还提供第二种方案,即前述任一所述中药组合物在制备治疗改善病毒性感冒发热症状药物上的应用。
本申请还提供第三种方案,即中药制剂,采用前述任一所述的中药组合物制备而成。
可选的,所述中药制剂的剂型包括汤剂、颗粒、片剂、膏剂中的任意一种。
可选的,所述中药制剂采用将所述中药组合物以水煎制成。、
与现有技术相比,本发明具有如下有益效果:
本申请中药组合物在同样缓解病毒性感冒各项伴随症状的同时,还可有效且快速改善病毒性感冒伴随的发热症状,起效快,减少反复,更有利于高热症状患者(例如39℃以上高热患者),以及更适用于婴幼儿高热或高热反复症状的患者。
具体实施方式
为使本申请实施例的目的、技术方案和优点更加清楚,下面将结合本申请实施例,对本申请实施例中的技术方案进行清楚、完整地描述,显然,所描述的实施例是本申请一部分实施例,而不是全部的实施例。通常在此处描述和示出的本申请实施例的组件可以以各种不同的配置来布置和设计。
本申请配方组分说明如下:
相比于现有技术,本申请采用的中药组合物由以下按重量份数计的各成分组成:
生地10~20份、玄参15~25份、苦参15~25份、金银花15~25份、连翘15~25份、牛蒡子15~25份、桔梗15~25份、薄荷5~10份、竹叶5~10份、荆芥10~20份 和甘草10~20份。
对于病毒性感冒,现有常用中药为抗病毒口服液,连花清瘟等。其主要治疗理论是以清热解毒,宣肺解表为主,病毒性感冒所引起的发烧的病理和中医传统理论结合来看,这样的治疗理论确实能缓解病毒性感冒的各项伴随症状,但依然存有起效慢,尤其是针对发热症状起效慢且反复的问题。
以连花清瘟为例,从其组方目的来看,其主要目的和方向为清热解毒,宣肺解表。在以宣肺解表为方向之下,以肺经为着眼点统顾全局,从而达到清热解毒的目的。
从病毒性感冒所引起的发烧的病理和中医传统理论结合来看,可以概括为,病毒性感冒所引起的发烧,是做为外因的病毒作用于人体后,在寻找五脏六腑的“短板”,并进行攻击继而发病。所以,仅以病毒性感冒所引起的发烧而言,并非仅以宣肺解表,可以快速奏效的。本申请中药组合物从人体的根本着手,兼顾多条经络的短板,进而达到从根本上解决的目的,即着眼于人体的阴阳调和,以滋阴为方向,兼顾清热解毒,宣肺解表,从而在缓解病毒性感冒各项伴随症状的同时,针对发热起效快且反复少,有效减少高热或反复高热可能带来的其他后遗症,尤其是婴幼儿高热或反复高热可能带来的其他后遗症。
本申请所述病毒性感冒为特指单纯型病毒性感冒,不包括细菌感染引起的感冒或细菌、病毒混合型感冒。因此,本申请病毒性感冒可包括普通感冒、流行性感冒和病毒性咽炎等。
上述中药组合物中,还可具体优选由以下按重量份数计的各成分组成:
生地10~15份、玄参15~20份、苦参15~20份、金银花15~20份、连翘15~20份、牛蒡子15~20份、桔梗15~20份、薄荷5~10份、竹叶5~10份、荆芥10~15份、甘草10~15份。
具体的,所述生地(拉丁学名:Rehmannia glutinosa Libosch) 别名生地黄,野地黄、山烟根等,为玄参科植物地黄的块根;属于清热凉血药,其药性甘、苦、寒,归于心、肝、肾经。具有清热凉血,养阴生津的功效。所述生地在本申请中药组合物中按重量份数计可采用10~15份,优选可选用10份、12份、15份,但不局限于此。
所述玄参(拉丁学名:Scrophularia ningpoensis Hemsl.)是玄参科、玄参属植物;清热解毒药;养阴。所述玄参在本申请中药组合物中按重量份数计可采用15~20份,优选可选用15份、18份、20份,但不局限于此。
所述苦参(拉丁学名:Sophora flavescens Alt.)是豆科、槐属草本或亚灌木植物;清热燥湿,杀虫,利尿。用于热痢,便血,黄疸尿闭,赤白带下,阴肿阴痒,湿疹,湿疮,皮肤瘙痒,疥癣麻风。所述苦参在本申请中药组合物中按重量份数计可采用15~20份,优选可选用15份、18份、20份,但不局限于此。
所述金银花,又名忍冬(拉丁学名:Lonicera japonica);清热解毒,凉散风热。用于痈肿疔疮,喉痹,丹毒,热血毒痢,风热感冒,温病发热。所述金银花在本申请中药组合物中按重量份数计可采用15~20份,优选可选用15份、18份、20份,但不局限于此。
所述连翘(拉丁学名:Forsythia suspensa):落叶灌木,是木樨科连翘属植物;清热,解毒,散结,消肿。治温热,丹毒,斑疹,痈疡肿毒,瘰疬,小便淋闭。所述连翘在本申请中药组合物中按重量份数计可采用15~20份,优选可选用15份、18份、20份,但不局限于此。
所述牛蒡子为菊科二年生草本植物牛蒡(拉丁学名:Arctium lappa L.)的干燥成熟果实,属于解表药中发散风热药。具有疏散风热,宣肺透疹,利咽散结,解毒消肿之功效。所述牛蒡子在本申请中药组合物中按重量份数计可采用15~20份,优选可选用15份、18份、20份,但不局限于此。
所述桔梗(拉丁学名:Platycodon grandiflorus),别名包袱花、铃铛花、僧帽花,是多年生草本植物;桔梗味苦、辛,性平。归肺经。功效宣肺、利咽、祛痰、排脓。所述桔梗在本申请中药组合物中按重量份数计15~20份,优选可选用15份、18份、20份,但不局限于此。
所述薄荷(拉丁学名:Mentha haplocalyx Briq. )土名叫“银丹草”,为唇形科植物,即同属其他干燥全草。具有风热感冒,风温初起,头痛,目赤,喉痹,口疮,风疹,麻疹,胸胁胀闷的功效与作用。所述薄荷在本申请中药组合物中按重量份数计可采用5~10份,优选可选用5份、8份、10份,但不局限于此。
所述竹叶(拉丁学名:Lophatherum gracile Brongn)为禾本科植物淡竹(竹子)的叶。具有清热除烦,生津,利尿之功效。所述竹叶在本申请中药组合物中按重量份数计可采用5~10份,优选可选用5份、8份、10份,但不局限于此。
所述荆芥(拉丁学名:Nepeta cataria L.),别名:香荆荠、线荠、四棱杆蒿、假苏,是唇形科、荆芥属多年生植物。所述荆芥为发汗,解热药,是常用草药之一,能镇痰、祛风、凉血。治流行感冒,头疼寒热发汗,呕吐。所述荆芥在本申请中药组合物中按重量份数计可采用10~15份,优选可选用10份、12份、15份,但不局限于此。
所述甘草(拉丁学名:Glycyrrhiza uralensis Fisch)别名:国老、甜草、乌拉尔甘草、甜根子。甘草具有补脾益气,清热解毒,祛痰止咳,缓急止痛,调和诸药功效。用于脾胃虚弱,倦怠乏力,心悸气短,咳嗽痰多,脘腹、四肢挛急疼痛,痈肿疮毒,缓解药物毒性、烈性。所述甘草在本申请中药组合物中按重量份数计可采用10~15份,优选可选用10份、12份、15份,但不局限于此。
对于本申请中药组合物而言,任一成分均是获取本申请能有效且快速改善病毒性感冒发热症状的中药组合物的关键。
以下各实施例均可以采用现有中药制剂的制备方法制备而成,例如可采用常规的水煎方式制成。
上述制备方法所采用的设备均可采用现有常规设备;所采用的各种成分均可以通过市售购买获得。
本申请中药组合物自成方十余年来,共治疗因病毒性感冒伴随的发热症状,约有上百例,尤其是对于婴幼儿的疗效显著,起效快,且少见反复。对于成人的疗效明显,偶见反复。仅目前而言,只要是病毒性感冒所引起的发烧无不显效,只会因个体的体质,年龄,病史等原因在显效时间上有所差异。但整体来件,基本起效时间均快于现有治疗病毒性感冒的中药制剂,且发热反复情况少。具体可参考下表,下表统计数据为近5年中的50件案例,案例具体情况不一一赘述。
表1:
患者年龄分布/岁 | 服药前体温范围 | 体温降低时服药次数 | 发热反复次数 | 其余症状情况 |
1~2 | 39.0~39.5 | 1~2 | 0~1 | 改善 |
2~3 | 39.0~39.3 | 1~2 | 0~1 | 改善 |
3~4 | 39.1~39.4 | 1~2 | 0~1 | 改善 |
4~6 | 39.2~39.5 | 1~2 | 1~2 | 改善 |
6~18 | 38.9~39.1 | 2~3 | 1~2 | 改善 |
大于18 | 39.0~39.2 | 2~3 | 2~4 | 改善 |
以下是上述表格中统计案例的典型案例:
典型实施例1
刘某某,男,生于2010年4月30日
2014年春,患病毒性感冒,高烧至39度5,在医院静脉注射三日,高烧始终不退,选取下述重量原料药:生地15克,玄参15克,苦参15克,金银花20克,连翘20克,牛蒡子15克,桔梗15克,薄荷5克,竹叶5克,荆芥10克,甘草10克,以水煎服。
患儿于傍晚服药十毫升左右,四小时后体温开始减退,午夜稍有反复,次日晨,体温游离在37度至38度之间,再服一次十毫升药剂,午时,体温降至37度以下,并有继续下降的趋势,傍晚时,体温回稳,在36度以上,并未再反复,辅以其他治疗方法后痊愈。
典型实施例2
许某某,女,生于1984年1月20日
2016年秋,患病毒性感冒发烧至39度,持续不退。选取下述重量原料药:生地15克,玄参15克,苦参20克,金银花15克,连翘15克,牛蒡子20克,桔梗20克,薄荷10克,竹叶10克,荆芥15克,甘草10克,以水煎服。
患者于午时服药20毫升左右,六小时后体温有所下降,但不明显,再服一剂20毫升药剂,午夜时分,体温降至38度,次日晨,又服一剂20毫升药剂,午时前,体温一度降至36度以下,随后逐渐回稳在36度以上,其后偶有波动,但未再服药,伴随其他治疗方法的跟进,逐渐痊愈。
典型实施例3
李某某,男,生于2009年12月4日
2018年初春,患者患病毒性感冒,初期口服药物治疗效果不明显,之后开始住院治疗,其他症状在住院期间逐渐减轻或消失,唯独持续低烧不见改善,体温始终在38度上下起落,绵延十余日未间断治疗,依然无效,随后选取下述重量原料药:
生地15克,玄参15克,苦参15克,金银花20克,连翘20克,牛蒡子15克,桔梗15克,薄荷5克,竹叶5克,荆芥10克,甘草10克,以水煎服。
患儿于中午服药十毫升左右,三小时之后体温开始骤降,体温最低时降至36度,五个小时后,体温再次攀升至37.5度左右,随后,调整原料药中生地的剂量后,选取下述重量原料药:
生地10克,玄参15克,苦参15克,金银花20克,连翘20克,牛蒡子15克,桔梗15克,薄荷5克,竹叶5克,荆芥10克,甘草10克,以水煎服。
第二日晨,服药十毫升左右,两小时后,体温稳定在36.8度以下,十小时后,又服十毫升左右,体温维持在36.5度以下,未再反复,辅以其他药物治疗后痊愈。
本方药性偏凉,患儿在首次服药后体温骤降至36度,不仅说明本方有效,同时也能看到,因患儿龄偏小,正常剂量方剂对患儿来说过于霸道,因此将本方中最凉性的生地减量,以求治病不伤根本的原则。
典型实施例4
齐某某,女,生于2003年5月9日
2017年五月,患者患病毒性感冒持续低烧,因其处在高考前夕,怕影响学习,无法住院治疗,持续一周后,出现高烧症状,体温已超过39度,随后选取下述重量原料药:
生地15克,玄参15克,苦参15克,金银花20克,连翘20克,牛蒡子15克,桔梗15克,薄荷5克,竹叶5克,荆芥10克,甘草10克,以水煎服。
患者于中午服药十毫升左右,四小时后,体温仅短暂降低1度后再次攀升至39度五,随后将原料药中牛蒡子增加至20克,薄荷增加至10克,选取下述重量原料药。
生地15克,玄参15克,苦参15克,金银花20克,连翘20克,牛蒡子20克,桔梗15克,薄荷10克,竹叶5克,荆芥10克,甘草10克,以水煎服。
当日晚六时,服药十毫升,三小时后,体温开始逐步下降,次日晨又服药十毫升,至午时体温已下降至37度,遂停药,辅以其他药物治疗。两日后,所有症状全部消失,期间体温未再反复。
本案中患者,不仅有病毒性感冒的症状,还有风寒束表的表征,所以调整了牛蒡子和薄荷的剂量,以加大解表剂量来辅助降低体温的目的。
典型实施例5
杨某某,男,生于2018年3月
2018年底患病毒性感冒出现持续高烧,最高体温40度。因其仅出生八个多月,体质较弱,恐难以受得了药物归经过程中的攻阀,所以,选取下述重量原料药:
生地10克,玄参15克,苦参15克,金银花15克,连翘15克,牛蒡子15克,桔梗15克,薄荷5克,竹叶5克,荆芥10克,甘草10克,以水煎服。
患儿于当日晚七时服药,午夜时体温便降至37度,次日晨体温升至38度,未再服药,但辅以其他药物治疗,傍晚时体温逐步停留在36.8度,未再反复。
典型实施例6
杜某,男,生于1975年,体重240余斤,2018年秋患病毒性感冒,住院治疗半月,始终发烧,体温始终在38至39度之间徘徊,随后选取下述重量原料药:
生地15克,玄参15克,苦参15克,金银花20克,连翘20克,牛蒡子15克,桔梗15克,薄荷5克,竹叶5克,荆芥10克,甘草10克 ,以水煎服。
治疗三日,服药三次,体温曾下探至37度,又出现反复,遂选取下述重量原料药:
生地20克,玄参25克,苦参25克,金银花25克,连翘25克,牛蒡子25克,桔梗25克,薄荷10克,竹叶10克, 荆芥20克,甘草20克,以水煎服。
患者服药六小时后,体温开始下降,12小时后,体温降至36.5度,随后反复至37.5度,两小时后,体温稳定在37度,随后停药,辅以其他药物治疗。
因患者体型庞大并伴有其他病症,所以按常人剂量给药,犹如隔靴搔痒,与其增加给药次数,不如增加药物纯度,以求内在扶正阴阳,外在解表透肌。
以上所述仅为本申请的优选实施例而已,并不用于限制本申请,对于本领域的技术人员来说,本申请可以有各种更改和变化。凡在本申请的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本申请的保护范围之内。
Claims (7)
1.改善病毒性感冒发热症状的中药组合物,其特征在于,所述中药组合物由以下按重量份数计的各成分制成:
生地10~15份、玄参15~20份、苦参15~20份、金银花15~20份、连翘15~20份、牛蒡子15~20份、桔梗15~20份、薄荷5~10份、竹叶5~10份、荆芥10~15份、甘草10~15份。
2.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物由以下按重量份数计的各成分制成:生地15份、玄参15份、苦参15份、金银花20份、连翘20份、牛蒡子15份、桔梗15份、薄荷5份、竹叶5份、荆芥10份、甘草10份。
3.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物由以下按重量份数计的各成分制成:生地15份、玄参15份、苦参15份、金银花20份、连翘20份、牛蒡子20份、桔梗15份、薄荷10份、竹叶5份、荆芥10份、甘草10份。
4.根据权利要求1所述的中药组合物,其特征在于,所述中药组合物由以下按重量份数计的各成分制成:生地10份、玄参15份、苦参15份、金银花20份、连翘20份、牛蒡子15份、桔梗15份、薄荷5份、竹叶5份、荆芥10份、甘草10份。
5.如权利要求1-4任一所述中药组合物在制备治疗改善病毒性感冒发热症状药物上的应用。
6.改善病毒性感冒发热症状的中药制剂,其特征在于,采用如权利要求1-4任一所述的中药组合物制备而成。
7.根据权利要求6所述的中药制剂,其特征在于,所述中药制剂的剂型包括汤剂、颗粒剂、片剂、膏剂中的任意一种。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210928792.3A CN115040613B (zh) | 2022-08-03 | 2022-08-03 | 改善病毒性感冒发热症状的中药组合物、应用及制剂 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202210928792.3A CN115040613B (zh) | 2022-08-03 | 2022-08-03 | 改善病毒性感冒发热症状的中药组合物、应用及制剂 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN115040613A CN115040613A (zh) | 2022-09-13 |
CN115040613B true CN115040613B (zh) | 2023-08-22 |
Family
ID=83167746
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202210928792.3A Active CN115040613B (zh) | 2022-08-03 | 2022-08-03 | 改善病毒性感冒发热症状的中药组合物、应用及制剂 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN115040613B (zh) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1348813A (zh) * | 2001-11-12 | 2002-05-15 | 北京中医药大学 | 抗流感病毒的药物有效部位及活性成分的分离制备方法 |
CN1872301A (zh) * | 2006-04-12 | 2006-12-06 | 曹存德 | 一种治疗感冒的中药 |
CN103505654A (zh) * | 2013-09-27 | 2014-01-15 | 广东恒诚制药有限公司 | 一种抗流感病毒复方中药制剂 |
-
2022
- 2022-08-03 CN CN202210928792.3A patent/CN115040613B/zh active Active
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1348813A (zh) * | 2001-11-12 | 2002-05-15 | 北京中医药大学 | 抗流感病毒的药物有效部位及活性成分的分离制备方法 |
CN1872301A (zh) * | 2006-04-12 | 2006-12-06 | 曹存德 | 一种治疗感冒的中药 |
CN103505654A (zh) * | 2013-09-27 | 2014-01-15 | 广东恒诚制药有限公司 | 一种抗流感病毒复方中药制剂 |
Non-Patent Citations (1)
Title |
---|
石钺,石任兵,刘斌,陆蕴如.银翘散抗流感病毒有效部位群中黄酮类成分的提取分离方法.中国中药杂志.-,2001,第26卷(第05期),320-322. * |
Also Published As
Publication number | Publication date |
---|---|
CN115040613A (zh) | 2022-09-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5336656B2 (ja) | 気管支炎を治療するための麻黄含有医薬組成物およびその調製方法 | |
CN102657805B (zh) | 一种枇杷花茶及其制备工艺 | |
CN103394070A (zh) | 治疗流行性感冒的中药制剂 | |
CN105012392A (zh) | 一种用于治疗鼻炎的中药组合物及其制备方法 | |
CN102205026A (zh) | 一种治疗小儿慢性鼻窦炎的中药组合物及其制备方法 | |
CN103768429A (zh) | 一种治疗急慢性咽炎的中药组合物及其制备方法 | |
CN101085228A (zh) | 一种内服治疗慢性咽炎的中药组合物 | |
CN115040613B (zh) | 改善病毒性感冒发热症状的中药组合物、应用及制剂 | |
CN105497723A (zh) | 一种治疗细菌性肺炎的中药制剂及其制备方法 | |
CN105055841A (zh) | 一种治疗慢性咽炎的药物及其制备方法 | |
CN113750188B (zh) | 一种中药组合物在制备治疗感冒药物中的应用 | |
CN110478416B (zh) | 治疗风湿性类风湿性关节炎的组合物及其制备方法和应用 | |
CN102526488B (zh) | 一种具有清咽功能的中药组合物 | |
CN105998840A (zh) | 一种用于治疗虫咬皮炎的外用药膏及制备方法 | |
CN101987116A (zh) | 一种对病毒性疱疹具有治疗作用的中药提取物及其制剂 | |
CN1840112A (zh) | 复方西羚解毒胶囊制剂及其制备方法 | |
CN111449465A (zh) | 一种药枕及其制备方法 | |
CN104740405B (zh) | 一种治疗过敏性紫癜性肾损害的中药制剂及制备方法 | |
CN113786436B (zh) | 一种中药组合物及其制剂和在治亚急性甲状腺炎中的应用 | |
CN117298183A (zh) | 一种治疗病毒性感冒的中药组合物及其制备方法和应用 | |
CN117838797A (zh) | 一种治疗结节的中药制剂-鹊踏草 | |
CN115192680A (zh) | 一种治疗流感的药物制备方法及其功效 | |
WO2024125422A1 (zh) | 用于防治新冠病毒感染的药物组合物及其制备方法和用途 | |
CN113230364A (zh) | 一种治疗小孩红屁股的中药膏剂 | |
CN115350220A (zh) | 一种治疗鼻炎的药剂 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |